REPLIGEN CORP (RGEN) Institutional Ownership
None of the superinvestors we track currently report REPLIGEN CORP (RGEN) in their latest SEC Form 13F filings.
13F filings cover institutional equity holdings and are reported quarterly with a delay. This stock may still have insider Form 4 activity or appear in future filings.
When tracked funds report positions in REPLIGEN CORP (RGEN), this page will show fund ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance.
Institutional Ownership Trend
| Portfolio quarter | Institutional holders | Total reported value | Total shares |
|---|---|---|---|
| Q3 2025 | 1 | $14,624,033 | 109,404 |
| Q2 2025 | 2 | $8,485,328 | 68,221 |
| Q1 2025 | 2 | $36,329,888 | 285,523 |
| Q4 2024 | 2 | $58,553,045 | 406,788 |
| Q3 2024 | 2 | $62,036,188 | 416,854 |
| Q2 2024 | 3 | $56,135,350 | 445,307 |
| Q1 2024 | 1 | $71,438,758 | 388,423 |
| Q4 2023 | 1 | $98,912,295 | 550,124 |
| Q3 2023 | 1 | $87,475,217 | 550,124 |
| Q3 2022 | 1 | $3,539 | 18,912 |
| Q2 2022 | 1 | $40,879 | 251,716 |
| Q1 2022 | 1 | $41,533 | 220,816 |
Related RGEN Institutional Insights:
- RGEN Institutional Ownership & Insiders Activity
- RGEN Institutional Ownership & 13F Activity
- RGEN Top Institutional Shareholders
- RGEN Institutional Buying Activity
- RGEN Institutional Selling Activity
- Institutional Portfolio Overlap & Shared Holdings
- RGEN Insider Trading & SEC Form 4 Activity
- Top Institutional Investor Stock Rankings